The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemoperfusion Market Research Report 2025
Synopsis
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.
The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemoperfusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoperfusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemoperfusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period.
Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.
The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemoperfusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoperfusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemoperfusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemoperfusion Market Overview
1.1 Product Definition
1.2 Hemoperfusion by Type
1.2.1 Global Hemoperfusion Market Value Comparison by Type (2024 VS 2031)
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Hemoperfusion by Application
1.3.1 Global Hemoperfusion Market Value by Application (2024 VS 2031)
1.3.2 Hepatic Encephalopathy
1.3.3 Certain Autoimmune Diseases
1.3.4 Drug Overdose
1.3.5 Specific Intoxications
1.3.6 Others
1.4 Global Hemoperfusion Market Size Estimates and Forecasts
1.4.1 Global Hemoperfusion Revenue 2020-2031
1.4.2 Global Hemoperfusion Sales 2020-2031
1.4.3 Global Hemoperfusion Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemoperfusion Market Competition by Manufacturers
2.1 Global Hemoperfusion Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemoperfusion Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemoperfusion, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemoperfusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemoperfusion, Product Type & Application
2.7 Global Key Manufacturers of Hemoperfusion, Date of Enter into This Industry
2.8 Global Hemoperfusion Market Competitive Situation and Trends
2.8.1 Global Hemoperfusion Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemoperfusion Players Market Share by Revenue
2.8.3 Global Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemoperfusion Market Scenario by Region
3.1 Global Hemoperfusion Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemoperfusion Sales by Region: 2020-2031
3.2.1 Global Hemoperfusion Sales by Region: 2020-2025
3.2.2 Global Hemoperfusion Sales by Region: 2026-2031
3.3 Global Hemoperfusion Revenue by Region: 2020-2031
3.3.1 Global Hemoperfusion Revenue by Region: 2020-2025
3.3.2 Global Hemoperfusion Revenue by Region: 2026-2031
3.4 North America Hemoperfusion Market Facts & Figures by Country
3.4.1 North America Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemoperfusion Sales by Country (2020-2031)
3.4.3 North America Hemoperfusion Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemoperfusion Market Facts & Figures by Country
3.5.1 Europe Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemoperfusion Sales by Country (2020-2031)
3.5.3 Europe Hemoperfusion Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemoperfusion Market Facts & Figures by Region
3.6.1 Asia Pacific Hemoperfusion Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemoperfusion Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemoperfusion Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemoperfusion Market Facts & Figures by Country
3.7.1 Latin America Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemoperfusion Sales by Country (2020-2031)
3.7.3 Latin America Hemoperfusion Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemoperfusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemoperfusion Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemoperfusion Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemoperfusion Sales by Type (2020-2031)
4.1.1 Global Hemoperfusion Sales by Type (2020-2025)
4.1.2 Global Hemoperfusion Sales by Type (2026-2031)
4.1.3 Global Hemoperfusion Sales Market Share by Type (2020-2031)
4.2 Global Hemoperfusion Revenue by Type (2020-2031)
4.2.1 Global Hemoperfusion Revenue by Type (2020-2025)
4.2.2 Global Hemoperfusion Revenue by Type (2026-2031)
4.2.3 Global Hemoperfusion Revenue Market Share by Type (2020-2031)
4.3 Global Hemoperfusion Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemoperfusion Sales by Application (2020-2031)
5.1.1 Global Hemoperfusion Sales by Application (2020-2025)
5.1.2 Global Hemoperfusion Sales by Application (2026-2031)
5.1.3 Global Hemoperfusion Sales Market Share by Application (2020-2031)
5.2 Global Hemoperfusion Revenue by Application (2020-2031)
5.2.1 Global Hemoperfusion Revenue by Application (2020-2025)
5.2.2 Global Hemoperfusion Revenue by Application (2026-2031)
5.2.3 Global Hemoperfusion Revenue Market Share by Application (2020-2031)
5.3 Global Hemoperfusion Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jafron Biomedical
6.1.1 Jafron Biomedical Company Information
6.1.2 Jafron Biomedical Description and Business Overview
6.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
6.1.5 Jafron Biomedical Recent Developments/Updates
6.2 Baxter (Gambro)
6.2.1 Baxter (Gambro) Company Information
6.2.2 Baxter (Gambro) Description and Business Overview
6.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
6.2.5 Baxter (Gambro) Recent Developments/Updates
6.3 Asahi-Kasei
6.3.1 Asahi-Kasei Company Information
6.3.2 Asahi-Kasei Description and Business Overview
6.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
6.3.5 Asahi-Kasei Recent Developments/Updates
6.4 Biosun Medical
6.4.1 Biosun Medical Company Information
6.4.2 Biosun Medical Description and Business Overview
6.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biosun Medical Hemoperfusion Product Portfolio
6.4.5 Biosun Medical Recent Developments/Updates
6.5 Kaneka
6.5.1 Kaneka Company Information
6.5.2 Kaneka Description and Business Overview
6.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kaneka Hemoperfusion Product Portfolio
6.5.5 Kaneka Recent Developments/Updates
6.6 Toray Medical
6.6.1 Toray Medical Company Information
6.6.2 Toray Medical Description and Business Overview
6.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Toray Medical Hemoperfusion Product Portfolio
6.6.5 Toray Medical Recent Developments/Updates
6.7 Cytosorbents
6.7.1 Cytosorbents Company Information
6.7.2 Cytosorbents Description and Business Overview
6.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cytosorbents Hemoperfusion Product Portfolio
6.7.5 Cytosorbents Recent Developments/Updates
6.8 Aier
6.8.1 Aier Company Information
6.8.2 Aier Description and Business Overview
6.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aier Hemoperfusion Product Portfolio
6.8.5 Aier Recent Developments/Updates
6.9 Zibo Kangbei
6.9.1 Zibo Kangbei Company Information
6.9.2 Zibo Kangbei Description and Business Overview
6.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
6.9.5 Zibo Kangbei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemoperfusion Industry Chain Analysis
7.2 Hemoperfusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemoperfusion Production Mode & Process Analysis
7.4 Hemoperfusion Sales and Marketing
7.4.1 Hemoperfusion Sales Channels
7.4.2 Hemoperfusion Distributors
7.5 Hemoperfusion Customer Analysis
8 Hemoperfusion Market Dynamics
8.1 Hemoperfusion Industry Trends
8.2 Hemoperfusion Market Drivers
8.3 Hemoperfusion Market Challenges
8.4 Hemoperfusion Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hemoperfusion Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hemoperfusion Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hemoperfusion Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hemoperfusion Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hemoperfusion Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hemoperfusion Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hemoperfusion Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hemoperfusion Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hemoperfusion, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemoperfusion, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemoperfusion, Product Type & Application
Table 12. Global Key Manufacturers of Hemoperfusion, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemoperfusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hemoperfusion Sales by Region (2020-2025) & (K Units)
Table 18. Global Hemoperfusion Sales Market Share by Region (2020-2025)
Table 19. Global Hemoperfusion Sales by Region (2026-2031) & (K Units)
Table 20. Global Hemoperfusion Sales Market Share by Region (2026-2031)
Table 21. Global Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hemoperfusion Revenue Market Share by Region (2020-2025)
Table 23. Global Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hemoperfusion Revenue Market Share by Region (2026-2031)
Table 25. North America Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 27. North America Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 28. North America Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hemoperfusion Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hemoperfusion Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hemoperfusion Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hemoperfusion Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hemoperfusion Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hemoperfusion Sales (K Units) by Type (2020-2025)
Table 51. Global Hemoperfusion Sales (K Units) by Type (2026-2031)
Table 52. Global Hemoperfusion Sales Market Share by Type (2020-2025)
Table 53. Global Hemoperfusion Sales Market Share by Type (2026-2031)
Table 54. Global Hemoperfusion Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hemoperfusion Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hemoperfusion Revenue Market Share by Type (2020-2025)
Table 57. Global Hemoperfusion Revenue Market Share by Type (2026-2031)
Table 58. Global Hemoperfusion Price (USD/Unit) by Type (2020-2025)
Table 59. Global Hemoperfusion Price (USD/Unit) by Type (2026-2031)
Table 60. Global Hemoperfusion Sales (K Units) by Application (2020-2025)
Table 61. Global Hemoperfusion Sales (K Units) by Application (2026-2031)
Table 62. Global Hemoperfusion Sales Market Share by Application (2020-2025)
Table 63. Global Hemoperfusion Sales Market Share by Application (2026-2031)
Table 64. Global Hemoperfusion Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hemoperfusion Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hemoperfusion Revenue Market Share by Application (2020-2025)
Table 67. Global Hemoperfusion Revenue Market Share by Application (2026-2031)
Table 68. Global Hemoperfusion Price (USD/Unit) by Application (2020-2025)
Table 69. Global Hemoperfusion Price (USD/Unit) by Application (2026-2031)
Table 70. Jafron Biomedical Company Information
Table 71. Jafron Biomedical Description and Business Overview
Table 72. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Jafron Biomedical Hemoperfusion Product
Table 74. Jafron Biomedical Recent Developments/Updates
Table 75. Baxter (Gambro) Company Information
Table 76. Baxter (Gambro) Description and Business Overview
Table 77. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Baxter (Gambro) Hemoperfusion Product
Table 79. Baxter (Gambro) Recent Developments/Updates
Table 80. Asahi-Kasei Company Information
Table 81. Asahi-Kasei Description and Business Overview
Table 82. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Asahi-Kasei Hemoperfusion Product
Table 84. Asahi-Kasei Recent Developments/Updates
Table 85. Biosun Medical Company Information
Table 86. Biosun Medical Description and Business Overview
Table 87. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biosun Medical Hemoperfusion Product
Table 89. Biosun Medical Recent Developments/Updates
Table 90. Kaneka Company Information
Table 91. Kaneka Description and Business Overview
Table 92. Kaneka Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Kaneka Hemoperfusion Product
Table 94. Kaneka Recent Developments/Updates
Table 95. Toray Medical Company Information
Table 96. Toray Medical Description and Business Overview
Table 97. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Toray Medical Hemoperfusion Product
Table 99. Toray Medical Recent Developments/Updates
Table 100. Cytosorbents Company Information
Table 101. Cytosorbents Description and Business Overview
Table 102. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cytosorbents Hemoperfusion Product
Table 104. Cytosorbents Recent Developments/Updates
Table 105. Aier Company Information
Table 106. Aier Description and Business Overview
Table 107. Aier Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Aier Hemoperfusion Product
Table 109. Aier Recent Developments/Updates
Table 110. Zibo Kangbei Company Information
Table 111. Zibo Kangbei Description and Business Overview
Table 112. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Zibo Kangbei Hemoperfusion Product
Table 114. Zibo Kangbei Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Hemoperfusion Distributors List
Table 118. Hemoperfusion Customers List
Table 119. Hemoperfusion Market Trends
Table 120. Hemoperfusion Market Drivers
Table 121. Hemoperfusion Market Challenges
Table 122. Hemoperfusion Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hemoperfusion
Figure 2. Global Hemoperfusion Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hemoperfusion Market Share by Type: 2024 & 2031
Figure 4. Activated Carbon Adsorption Product Picture
Figure 5. Resin Adsorption Product Picture
Figure 6. Global Hemoperfusion Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Hemoperfusion Market Share by Application: 2024 & 2031
Figure 8. Hepatic Encephalopathy
Figure 9. Certain Autoimmune Diseases
Figure 10. Drug Overdose
Figure 11. Specific Intoxications
Figure 12. Others
Figure 13. Global Hemoperfusion Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hemoperfusion Market Size (2020-2031) & (US$ Million)
Figure 15. Global Hemoperfusion Sales (2020-2031) & (K Units)
Figure 16. Global Hemoperfusion Average Price (USD/Unit) & (2020-2031)
Figure 17. Hemoperfusion Report Years Considered
Figure 18. Hemoperfusion Sales Share by Manufacturers in 2024
Figure 19. Global Hemoperfusion Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Hemoperfusion Players: Market Share by Revenue in Hemoperfusion in 2024
Figure 21. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Hemoperfusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 24. North America Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 28. Europe Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 29. Germany Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Hemoperfusion Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Hemoperfusion Revenue Market Share by Region (2020-2031)
Figure 36. China Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 46. Latin America Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Hemoperfusion Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Hemoperfusion Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Hemoperfusion by Type (2020-2031)
Figure 56. Global Revenue Market Share of Hemoperfusion by Type (2020-2031)
Figure 57. Global Hemoperfusion Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Hemoperfusion by Application (2020-2031)
Figure 59. Global Revenue Market Share of Hemoperfusion by Application (2020-2031)
Figure 60. Global Hemoperfusion Price (USD/Unit) by Application (2020-2031)
Figure 61. Hemoperfusion Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
